Company seeks to raise funds through a rights issue up to EUR 15 million.
- Bioretec Ltd aims to raise between EUR 5 million and EUR 15 million.
- The rights issue will involve issuance of up to 1.5 billion new shares.
- Funds raised will be used to support company operations.
Bioretec Ltd has announced its intention to conduct a rights issue aiming to raise between EUR 5 million and EUR 15 million. This financial strategy involves the potential issuance of up to 1.5 billion new shares, giving current shareholders the opportunity to purchase additional shares at a set price. The company seeks this funding to bolster its ongoing operations and support strategic initiatives.
The rights issue is designed to allow shareholders to maintain their proportional ownership in Bioretec Ltd while contributing to the financial stability and growth of the company. Interested investors will be provided with further details, including the terms and timing of the issuance. This move reflects Bioretec's commitment to navigating its future financial landscape effectively.
